Research progress in intratumoral heterogeneity and clinical significance of ovarian cancer

被引:7
作者
Pu, Tengda [1 ]
Zhang, Chengyuan [1 ]
Su, Bingfeng [1 ]
Li, Li [1 ]
Fu, Jingjing [1 ]
机构
[1] Hainan Canc Hosp, Dept Gynecolgy, Haikou, Peoples R China
关键词
individualized treatment; intratumoral heterogeneity; ovarian cancer; precision medicine; MOLECULAR PATHOGENESIS; CARCINOMA; ORIGIN; GRADE;
D O I
10.1097/MD.0000000000036074
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Intratumoral heterogeneity has been a hot topic of cancer research in recent years, which has become a part of resolving cancer metastasis, recurrence and drug resistance. Intratumoral heterogeneity shows that cells undergo different division and proliferation during the process of tumor development, and their genomic cells exist in the process of tumor development. Protein and epigenetic changes can lead to differences in proliferation, migration and invasion, sensitivity and pharmacological prognosis of tumor cells, promote sustainable development and development of cancer cells, produce greater adaptability, and lead to metastasis, recurrence and drug resistance of malignant tumors. In recent years, the molecular mechanism and clinical application of intratumoral heterogeneity have captivated widespread attention from researchers. In the era of precision medicine, oncologists attempt to improve the clinical efficacy of targeted tumor therapy via intratumoral heterogeneity. In this article, recent advances in the study of intratumoral heterogeneity, molecular mechanism of intratumoral heterogeneity, systematic evolution and quantification and clinical significance of tumor heterogeneity were reviewed.
引用
收藏
页数:4
相关论文
共 22 条
[1]   Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling [J].
Bashashati, Ali ;
Ha, Gavin ;
Tone, Alicia ;
Ding, Jiarui ;
Prentice, Leah M. ;
Roth, Andrew ;
Rosner, Jamie ;
Shumansky, Karey ;
Kalloger, Steve ;
Senz, Janine ;
Yang, Winnie ;
McConechy, Melissa ;
Melnyk, Nataliya ;
Anglesio, Michael ;
Luk, Margaret T. Y. ;
Tse, Kane ;
Zeng, Thomas ;
Moore, Richard ;
Zhao, Yongjun ;
Marra, Marco A. ;
Gilks, Blake ;
Yip, Stephen ;
Huntsman, David G. ;
McAlpine, Jessica N. ;
Shah, Sohrab P. .
JOURNAL OF PATHOLOGY, 2013, 231 (01) :21-34
[2]   Integrated genomic analyses of ovarian carcinoma [J].
Bell, D. ;
Berchuck, A. ;
Birrer, M. ;
Chien, J. ;
Cramer, D. W. ;
Dao, F. ;
Dhir, R. ;
DiSaia, P. ;
Gabra, H. ;
Glenn, P. ;
Godwin, A. K. ;
Gross, J. ;
Hartmann, L. ;
Huang, M. ;
Huntsman, D. G. ;
Iacocca, M. ;
Imielinski, M. ;
Kalloger, S. ;
Karlan, B. Y. ;
Levine, D. A. ;
Mills, G. B. ;
Morrison, C. ;
Mutch, D. ;
Olvera, N. ;
Orsulic, S. ;
Park, K. ;
Petrelli, N. ;
Rabeno, B. ;
Rader, J. S. ;
Sikic, B. I. ;
Smith-McCune, K. ;
Sood, A. K. ;
Bowtell, D. ;
Penny, R. ;
Testa, J. R. ;
Chang, K. ;
Dinh, H. H. ;
Drummond, J. A. ;
Fowler, G. ;
Gunaratne, P. ;
Hawes, A. C. ;
Kovar, C. L. ;
Lewis, L. R. ;
Morgan, M. B. ;
Newsham, I. F. ;
Santibanez, J. ;
Reid, J. G. ;
Trevino, L. R. ;
Wu, Y. -Q. ;
Wang, M. .
NATURE, 2011, 474 (7353) :609-615
[3]   Prevention, Screening, Treatment and Follow-Up of Gynecological Cancers: State of Art and Future Perspectives [J].
D'Auge, Tullio Golia ;
Giannini, Andrea ;
Bogani, Giorgio ;
Di Dio, Camilla ;
Lagana, Antonio Simone ;
Di Donato, Violante ;
Salerno, Maria Giovanna ;
Caserta, Donatella ;
Chiantera, Vito ;
Vizza, Enrico ;
Muzii, Ludovico ;
D'Oria, Ottavia .
CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2023, 50 (08)
[4]   Pathogenetic Pathways in Ovarian Endometrioid Adenocarcinoma A Molecular Study of 29 Cases [J].
Geyer, Julia Turbiner ;
Angeles Lopez-Garcia, Maria ;
Sanchez-Estevez, Carolina ;
Sarrio, David ;
Moreno-Bueno, Gema ;
Franceschetti, Ilaria ;
Palacios, Jose ;
Oliva, Esther .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2009, 33 (08) :1157-1163
[5]   PARP Inhibitors in Newly Diagnosed and Recurrent Ovarian Cancer [J].
Giannini, Andrea ;
Di Dio, Camilla ;
Di Donato, Violante ;
D'oria, Ottavia ;
Salerno, Maria Giovanna ;
Capalbo, Giuseppe ;
Cuccu, Ilaria ;
Perniola, Giorgia ;
Muzii, Ludovico ;
Bogani, Giorgio .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2023, 46 (09) :414-419
[6]   Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates [J].
Gurung, Ananta ;
Hung, Tawny ;
Morin, Jason ;
Gilks, C. Blake .
HISTOPATHOLOGY, 2013, 62 (01) :59-70
[7]   Genomic and transcriptomic plasticity in treatment-naive ovarian cancer [J].
Hoogstraat, Marlous ;
de Pagter, Mirjam S. ;
Cirkel, Geert A. ;
van Roosmalen, Markus J. ;
Harkins, Timothy T. ;
Duran, Karen ;
Kreeftmeijer, Jennifer ;
Renkens, Ivo ;
Witteveen, Petronella O. ;
Lee, Clarence C. ;
Nijman, Isaac J. ;
Guy, Tanisha ;
van 't Slot, Ruben ;
Jonges, Trudy N. ;
Lolkema, Martijn P. ;
Koudijs, Marco J. ;
Zweemer, Ronald P. ;
Voest, Emile E. ;
Cuppen, Edwin ;
Kloosterman, Wigard P. .
GENOME RESEARCH, 2014, 24 (02) :200-211
[8]   Genetic intra-tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours [J].
Khalique, L. ;
Ayhan, A. ;
Weale, M. E. ;
Jacobs, I. J. ;
Ramus, S. J. ;
Gayther, S. A. .
JOURNAL OF PATHOLOGY, 2007, 211 (03) :286-295
[9]   Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (Review) [J].
Kobayashi, Hiroshi ;
Kajiwara, Hirotaka ;
Kanayama, Seiji ;
Yamada, Yoshihiko ;
Furukawa, Naoto ;
Noguchi, Taketoshi ;
Haruta, Shoji ;
Yoshida, Shozo ;
Sakata, Mariko ;
Sado, Toshiyuki ;
Oi, Hidekazu .
ONCOLOGY REPORTS, 2009, 22 (02) :233-240
[10]   Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-Shifting the paradigm [J].
Kurman, Robert J. ;
Shih, Ie-Ming .
HUMAN PATHOLOGY, 2011, 42 (07) :918-931